Barclays’s Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 CRHC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-77,403
Closed -$34K 5305
2022
Q2
$34K Buy
77,403
+40,003
+107% +$29.1K ﹤0.01% 4200
2022
Q1
$29K Buy
+37,400
New +$26.5K ﹤0.01% 4323

Other funds holding CRHC.WS

Barclays's CRHC.WS Position: Q3 2022 in Review

Barclays sold out of Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (CRHC.WS) in Q3 2022, closing a stake of 77,403 shares — an estimated $34K sold.

Barclays first reported a position in CRHC.WS in Q1 2022 and held it in 2 quarters. The position peaked at $34K in Q2 2022. 47 funds tracked by Wall St. Rank hold CRHC.WS as of Q3 2022.

  • Barclays reported no remaining Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
  • Barclays sold 77,403 Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2022, an estimated $34K.
  • Barclays first reported a position in Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2022 and held it in 2 quarters.
  • Barclays's Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $34K in Q2 2022.
  • 47 funds tracked by Wall St. Rank held Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2022.

Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.